BDP achieves CEIV pharma certification

By Rebecca Jeffrey

Photo: Pixabay

Three BDP International office locations have achieved Center of Excellence for Independent Validators (CEIV) in pharmaceutical logistics certifications from IATA.

The logistics and transportation solutions company’s Brussels, Belgium, Milan, Italy, and JFK, New York, locations have completed training that aims to enable international compliance standards to safeguard pharmaceutical product integrity during the transportation process.

IATA developed CEIV Pharma to assist the air cargo supply chain by establishing a common baseline from existing regulations and standards.

The certification confirms that the company’s handling of pharmaceutical products meets the IATA Temperature Control Regulations (TCR) and international standards and best practices, including those of the World Health Organization, European Union Good Distribution Practices (GDP), and the United States Pharmacopeia standards.

“Ensuring product quality is a significant challenge for the pharmaceutical industry,” said Simona Ravera, BDP’s director of sales for life sciences, EMEA. “With the CEIV certification, our customers around the world can trust that their logistics partner is invested in the highest quality standards for their high-quality products.”

BDP offers ocean, air, and ground transportation services.

Share this story

Related Topics

Latest pharma logistics news

Vienna Airport sees pharma volumes grow as Austrian signs up to VPHC

By Damian Brett

Austrian Airlines has signed up to use the Vienna Airport Pharma Handling Center (VPHC) for all of its cargo volumes…

Read More

Share this story

Air Cargo News Awards entry deadline extended

By Damian Brett

In response to high demand, companies now have an extra week to submit their entries for the Air Cargo News…

Read More

Share this story

Edmonton Airport’s Caswell elected chairman of Pharma.Aero

By Damian Brett

Trevor Caswell of Edmonton International Airport has been elected as the new chairman of the Pharma.Aero industry group’s board of…

Read More

Share this story